Differences in Postoperative Symptoms With Four Ureteral Stents
Launched by UNIVERSITY OF WISCONSIN, MADISON · Oct 9, 2023
Trial Information
Current as of August 25, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the differences in symptoms that patients experience after having different types of ureteral stents placed during surgery to remove kidney stones. There are four types of stents being compared: two different sizes of the Percuflex stent and two different sizes of the Tria stent. The aim is to see if the type of stent used affects how patients feel after the surgery. The trial will involve 272 participants and will last for about 10 weeks.
To be eligible for the trial, participants need to have kidney stones that require endoscopic treatment and stent placement. However, pregnant women, patients with kidney transplants, and those with certain medical conditions will not be included. Participants can expect to be monitored for their symptoms throughout the study period. This trial is currently recruiting and welcomes individuals aged 18 and older who meet the criteria. It’s important to note that this study is focusing on improving patient comfort and understanding the best options for stent placement after kidney stone surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients with renal or ureteral urinary stones who require endoscopic treatment and stent placement in the outpatient operating room.
- Exclusion Criteria:
- • Pregnant patients
- • Patients with transplant kidneys
- • Patients with irreversible coagulopathy
- • Patients with known ureteral stricture disease
- • Non-English speaking, vulnerable patients such as lacking of decision-making capability, prisoner, adult unable to consent, will not be enrolled.
- • Patients with planned staged procedures.
- • Patients who have stent placed before surgery.
About University Of Wisconsin, Madison
The University of Wisconsin-Madison is a leading research institution renowned for its commitment to advancing healthcare through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university leverages its extensive resources, including cutting-edge facilities and a diverse pool of expert researchers, to conduct rigorous studies that address critical health challenges. The institution's focus on translating research findings into practical applications fosters the development of new treatments and interventions, ultimately contributing to improved patient outcomes and public health initiatives. As a sponsor of clinical trials, the University of Wisconsin-Madison is dedicated to upholding the highest ethical standards and ensuring participant safety throughout the research process.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Madison, Wisconsin, United States
Patients applied
Trial Officials
Ali Antar, MD
Principal Investigator
University of Wisconsin, Madison
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported